Precigenetics uses semiconductor manufacturing techniques for observing living cells. This approach allows real-time drug interaction studies within miniature life-support systems. The company aims to build a vast database of cellular responses to medicines. This data will empower artificial intelligence for accelerated drug discovery processes. Their work focuses on liver toxicity and melanoma models initially.
Read more at the source
Disclaimer: The content of this post is sourced from external sites and is for informational purposes only. All rights and credits belong to the original authors and publishers.